Risultati della ricerca - Shanthakumar Tyavanagimatt
- Mostra 1 - 9 risultati su 9
-
1
Development of ST-246® for Treatment of Poxvirus Infections di Robert Jordan, Janet M. Leeds, Shanthakumar Tyavanagimatt, Dennis E. Hruby
Pubblicazione 2010Artigo -
2
Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor di Robert Jordan, Deborah Tien, Tové C. Bolken, Kevin F. Jones, Shanthakumar Tyavanagimatt, Josef Strasser, Annie Frimm, Michael L. Corrado, Phoebe G. Strome, Dennis E. Hruby
Pubblicazione 2008Artigo -
3
A potent Lassa virus antiviral targets an arenavirus virulence determinant di Ikenna G. Madu, Megan Files, Dima Gharaibeh, Amy L. Moore, Kie-Hoon Jung, Brian B. Gowen, Dongcheng Dai, Kevin F. Jones, Shanthakumar Tyavanagimatt, James R. Burgeson, Marcus J. Korth, Kristin Bedard, Shawn P. Iadonato, Sean M. Amberg
Pubblicazione 2018Artigo -
4
A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein di Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach, Aklile Berhanu, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Kristin A. Wineinger, Jessica Pagé, Chris Harver, Eric Stavale, Shanthakumar Tyavanagimatt, Melialani A. Stone, Ralf Bartenschlager, Pietro Scaturro, Dennis E. Hruby, Robert Jordan
Pubblicazione 2012Artigo -
5
Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers di Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt, Janet M. Leeds, Tové C. Bolken, Kevin F. Jones, Robert Jordan, Thomas Marbury, Jon Ruckle, Denis Mee-Lee, Eric A. Ross, Israel Lichtenstein, Margaret Pickens, Michael L. Corrado, Jean Μ. Clarke, Annie Frimm, Dennis E. Hruby
Pubblicazione 2012Artigo -
6
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis di Stephen T. Oh, Ruben A. Mesa, Claire Harrison, Prithviraj Bose, Aaron T. Gerds, Vikas Gupta, Bart L. Scott, Jean‐Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah Buckley, Shanthakumar Tyavanagimatt, Bryan Harder, Karisse Roman‐Torres, Jennifer A. Smith, Adam R. Craig, John Mascarenhas, Srđan Verstovšek
Pubblicazione 2023Artigo -
7
ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification di Robert Jordan, Arthur J. Goff, Annie Frimm, Michael L. Corrado, Lisa E. Hensley, Chelsea M. Byrd, Eric M. Mucker, Josh Shamblin, Tové C. Bolken, Carly Wlazlowski, Wendy Johnson, Jennifer Chapman, Nancy Twenhafel, Shanthakumar Tyavanagimatt, Adams Amantana, Jarasvech Chinsangaram, Dennis E. Hruby, John W. Huggins
Pubblicazione 2009Artigo -
8
Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase di Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu, Dongcheng Dai, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Guang Yang, Shanthakumar Tyavanagimatt, Chris Harver, Kristin A. Wineinger, Jessica Pagé, Eric Stavale, Melialani A. Stone, Kathleen Fuller, Candace Lovejoy, Janet M. Leeds, Dennis E. Hruby, Robert Jordan
Pubblicazione 2013Artigo -
9
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis di Aaron T. Gerds, Michael R. Savona, Bart L. Scott, Moshe Talpaz, Miklós Egyed, Claire Harrison, Abdulraheem Yacoub, Alessandro M. Vannucchi, Adam J. Mead, Jean‐Jacques Kiladjian, Jennifer O’Sullivan, Valentín García‐Gutiérrez, Prithviraj Bose, Raajit K. Rampal, Carole B. Miller, Jeanne Palmer, Stephen T. Oh, Sarah Buckley, Diane R. Mould, Kaori Ito, Shanthakumar Tyavanagimatt, Jennifer A. Smith, Karisse Roman‐Torres, Sri Devineni, Adam R. Craig, John Mascarenhas
Pubblicazione 2020Artigo
Strumenti per la ricerca:
Soggetti correlati
Biochemistry
Biology
Medicine
Pharmacology
Virology
Virus
Antiviral drug
Gene
Internal medicine
Pharmacokinetics
Adverse effect
Orthopoxvirus
Recombinant DNA
Vaccinia
Alternative medicine
Anemia
Bone marrow
Dengue fever
Dengue virus
Immunology
In vitro
Monkeypox
Myelofibrosis
Pathology
Placebo
Ruxolitinib
Tolerability
Viral replication
Viremia
Anesthesia